作者
R Michael Tuttle, Sukhjeet Ahuja, Anca M Avram, Victor J Bernet, Patrick Bourguet, Gilbert H Daniels, Gary Dillehay, Ciprian Draganescu, Glenn Flux, Dagmar Führer, Luca Giovanella, Bennett Greenspan, Markus Luster, Kristoff Muylle, Johannes WA Smit, Douglas Van Nostrand, Frederik A Verburg, Laszlo Hegedüs
发表日期
2019/4/1
来源
Thyroid
卷号
29
期号
4
页码范围
461-470
出版商
Mary Ann Liebert, Inc., publishers
简介
Background: Publication of the 2015 American Thyroid Association (ATA) management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met with disagreement by the extended nuclear medicine community with regard to some of the recommendations related to the diagnostic and therapeutic use of radioiodine (131I). Because of these concerns, the European Association of Nuclear Medicine and the Society of Nuclear Medicine and Molecular Imaging declined to endorse the ATA guidelines. As a result of these differences in opinion, patients and clinicians risk receiving conflicting advice with regard to several key thyroid cancer management issues.
Summary: To address some of the differences in opinion and controversies associated with the therapeutic uses of 131I in differentiated thyroid cancer constructively, the ATA, the European Association of Nuclear Medicine, the …
学术搜索中的文章
RM Tuttle, S Ahuja, AM Avram, VJ Bernet, P Bourguet… - Thyroid, 2019